NCT06900296View on ClinicalTrials.gov

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 31, 2026

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions

Cancer

Trial Locations (1)

46202

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

All Listed Sponsors

collaborator

Indiana Institute of Personalized Medicine

UNKNOWN

lead

Indiana University

OTHER